15 employees
AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.
2019
$5M
from 2 investors over 2 rounds
ARTHEx Biotech raised $5M on July 24, 2020
Investors: AdBio partners
ARTHEx Biotech raised $1.3M on June 1, 2020
Investors: CDTI, Centre for the Development of Industrial Technology